Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction

Background: Type 2 sodium-glucose cotransporter inhibitors (SGLT2i) are among the main therapeutic options for patients with chronic heart failure with reduced ejection fraction (HFrEF). The aim of this study was to evaluate the effects of SGLT2i on the echocardiographic parameters of left (LV) and...

Повний опис

Бібліографічні деталі

Автори:	Gianmarco Alcidi, Rosanna Pugliese, Sara Ioannoni, Matteo Romano, Gianpaolo Palmieri, Erika Tabella, Michele Correale, Matteo Di Biase, Natale Daniele Brunetti, Massimo Iacoviello
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2023-10-01
Серія:	Clinics and Practice
Предмети:	heart failure with reduced ejection fraction type 2 sodium-glucose cotransporter inhibitors cardiac function two-dimensional speckle tracking
Онлайн доступ:	https://www.mdpi.com/2039-7283/13/6/116
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!